ScholarIQanswers from OpenAlex

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis

PaperCitations, authors & open-access status

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis have?

ScholarIQcitation count

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis has 61 citations in the OpenAlex counts ScholarIQ stores.

When was Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis published?

ScholarIQyear

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis has 2012 year in the ScholarIQ index.

What is the open-access status of Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis?

ScholarIQoa status

Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis has gold oa status in the ScholarIQ index.

What is the DOI of Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis?

ScholarIQdoi

The DOI for Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis is on the source record.

What is the PMID of Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis?

ScholarIQpmid

The PMID for Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis is on the source record.

What is the OpenAlex record for Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis?

ScholarIQopenalex

The OpenAlex for Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial